Lyft misses quarterly revenue estimates on competition, weak US travel demand
Larger rival Uber Technologies, which offers ride-hailing, food and grocery delivery business globally, issued an upbeat forecast for the third-quarter earlier in the day, thanks to its efforts to boost engagement across its unified platform.
Lyft's revenue of $1.59 billion in the second quarter missed estimates of $1.61 billion, according to data compiled by LSEG.
The company recently completed its nearly $200 million acquisition of European mobility platform FreeNow and has signed a deal with China's Baidu to introduce the search engine giant's robotaxis in the region.
Lyft on Wednesday also announced a partnership, set to launch later this year, with United Airlines that will allow the carrier's customers to earn rewards on all Lyft rides.
With partnerships including DoorDash and Chase already in place, Lyft's entry into Europe positions the company to extend such collaborations into international markets.
Lyft said it expects gross bookings to be between $4.65 billion and $4.80 billion for the third quarter, well above estimates of $4.59 billion.
With growth stagnating in major U.S. metros, ride-hailing companies are shifting their focus to medium and smaller car-dependent cities to tap into new markets and drive revenue.
Lyft recorded an adjusted core earnings of $129.4 million in the second quarter, above the average estimate of $124.5 million.
It forecast current-quarter core earnings of $125 million to $145 million, largely in line with Wall Street estimates.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Trump's Fed pick, Bank of England's 'hawkish' cut weigh on dollar
By Jaspreet Kalra and Ankur Banerjee SINGAPORE (Reuters) -The dollar was under pressure on Friday and was on course for a weekly fall as U.S. President Donald Trump's temporary choice for a fill-in Federal Reserve Governor stoked expectations for a dovish pick to replace chair Jerome Powell when his term ends. Sterling hovered near a two-week high, clinging to Thursday's sharp gains as the Bank of England cut interest rates but only after a narrow 5-4 vote, which showed the central bank's easing bias lacked conviction. Meanwhile, Trump's decision to nominate Council of Economic Advisers Chairman Stephen Miran to serve on a newly vacant seat at the Fed, while White House seeks a permanent addition, weighed on the dollar. Miran replaces Governor Adriana Kugler following her surprise resignation last week. "While we expect Miran to advocate for lower interest rates, we do not consider he will push the FOMC to cut the Funds rate if the data does not support a cut," said Joseph Capurso, head of international economics at the Commonwealth Bank of Australia. "Depending on the president's perception of his performance, he may also be a contender to replace Chair Powell when his term ends in May." Trump has repeatedly criticised Powell for not cutting interest rates, and while he has backed off threats to oust Powell before his term ends on May 15, has accelerated the search for a replacement. Fed Governor Christopher Waller is emerging as a top candidate to be the next chair, Bloomberg news reported on Thursday. Against a basket of peers, the dollar is down nearly 0.7% on the week so far as concerns over softening U.S. economic momentum, especially in the labour market, boosted hopes of Fed rate cuts. The dollar index was last at 98.04 in early trading on Friday. The Japanese yen was flat at 147.07 per dollar. Adam Grotzinger, senior fixed income portfolio manager at Neuberger Berman, expects four consecutive rate cuts from the Fed totalling 100 basis points, starting later this year and finishing early next year. "When we're looking at economic data, don't be surprised by softer prints coming in on the economy in Q3," Grotzinger said. "That said, for the full year we expect kind of an okay growth, but slower than the last couple years." Traders are pricing in a 93% chance of a rate cut in September with at least two rate cuts priced in by the end of the year. Atlanta Fed president Raphael Bostic said on Thursday that while risks to the job market have increased, it remains too soon to commit to rate cuts with more data lined up ahead of the Fed's policy review scheduled for September 16-17. The BOE's split vote on Thursday showed policymakers remained concerned about still high inflation, even as it cut rates. The pound was nearly flat at $1.3439 on Friday, holding the previous session's gains and on course to clock its best weekly performance since late June. The vote-split in the BoE meeting "implies one of the most hawkish versions of a 25bp cut that reasonable could have been expected," analysts at Goldman Sachs said. Elsewhere, the euro was perched near a two-week high as investors found comfort in the prospect of talks between the U.S. and Russia aimed at ending the war in Ukraine. Russian President Vladimir Putin and U.S. President Donald Trump will meet in the coming days, Kremlin aide Yuri Ushakov said on Thursday. This would mark the first summit between leaders of the U.S. and Russia since June 2021. With the Kremlin announcing summit plans, "geopolitics are in the spotlight and likely to be the major driver of FX markets heading into the weekend," analysts at ANZ wrote in a Friday note. Sign in to access your portfolio
Yahoo
5 minutes ago
- Yahoo
Bank of America Sees 5 Market Drivers in Play — and Suggests 2 Stocks to Buy
After a steady climb through much of July, the stock market has shown signs of cooling in early August. Mixed economic data, including a softer-than-expected jobs report, and renewed concerns about inflation have introduced a dose of caution among investors. Still, the broader uptrend is holding, with both the S&P 500 and Nasdaq in positive territory for the year. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Against this backdrop, Bank of America sees five key factors aligning that could set the stage for the market's next leg higher. These include a 'political will' to drive short-term strength ahead of next year's midterm US elections; the impact of the recent 'Big Beautiful Bill' on U.S. manufacturing; the likelihood of substantial economic stimulus in Europe, particularly from Germany; a surge in capital expenditures on Wall Street, especially among the 'Magnificent 7' hyperscalers; and finally, BofA's proprietary 'regime indicator,' a historically accurate set of predictive signals that is starting to show signs of a recovery in the making. With those drivers potentially in play, BofA's analysts are sharpening their focus on the stocks they believe are positioned to ride the next wave. Two names in particular stand out, and we've turned to the TipRanks database to see what sets them apart. Let's dive in. Brown & Brown (BRO) We'll start in the insurance industry, where Brown & Brown is a specialist in risk management. The company has been in business since 1939 and is based in Daytona Beach, Florida. Brown & Brown offers policies across a wide range of categories, including property & casualty, employee benefits, and personal insurance. Its specialties span dealer services in the automotive industry, enterprise-scale risk solutions, and even tribal policies tailored to the specific needs of various Indian tribes. From those modest beginnings, Brown & Brown has evolved into a major industry player. It now employs over 17,000 people across more than 500 locations and has extended its presence to nearly 20 countries. Backed by $4.8 billion in annual revenue and a market cap exceeding $30 billion, the company is firmly established as a force in the global insurance landscape. Brown & Brown released its 2Q25 results on July 28, posting several encouraging data points. Quarterly revenue came in at $1.3 billion, slightly ahead of estimates and up 9.1% year-over-year. Adjusted diluted EPS also impressed, climbing 10 cents from the prior year to reach $1.03, 4 cents above consensus. However, those solid headline numbers weren't enough to satisfy the market. The stock fell as investors reacted to a weaker GAAP EPS of $0.78, down 13% from the year-ago quarter, and signs of margin compression. Organic revenue growth slowed to just 3.6%, raising questions about the quality of top-line expansion, which appeared heavily acquisition-driven. Broader industry challenges, such as softening insurance rates and mounting cost pressures, added to investor unease. For Bank of America analyst Joshua Shanker, this pullback may present a compelling entry point. He argues that Brown & Brown remains fundamentally strong, even if the stock has underperformed. 'BRO shares have fallen 26% since April 2, while the S&P 500 has appreciated 12%. This would represent one of the most significant periods of snap underperformance in BRO's history. The stock is now trading near trough valuations relative to the insurance broker peers whereas it has typically traded at a thick premium. Our EPS forecasts run ahead of consensus, and we believe that 2Q25 results have reset the outlook to a more steady-state growth rate. With material upside to our price objective, we believe investors should buy shares of Brown & Brown,' Shanker opined. That bullish stance is underscored by his new Buy rating and a $130 price target, implying a potential upside of ~42% over the next year. (To watch Shanker's track record, click here) Shanker's optimism aligns with a broader, albeit more cautious, sentiment on Wall Street. Brown & Brown has earned a Moderate Buy consensus rating based on 12 recent analyst reviews, which include 5 Buys, 6 Holds, and 1 Sell. The stock currently trades at $91.80, and the average price target of $111.40 suggests room for a 21% gain in the year ahead. (See BRO stock forecast) Surgery Partners (SGRY) The next BofA pick we'll look at, Surgery Partners, works as an adjunct in the healthcare field, providing surgical facilities and ancillary services in 200 locations in more than 30 states. The company acts as a link between providers and patients, offering expertise in general surgery, hand surgery, dermatology, oncology, plastic surgery, and anesthesia, to name just a few of the specialties available. The company got its start in 2004, and today works through a network of partnerships with healthcare systems, surgical hospitals, ambulatory surgery centers, and physician practices. Surgery Partners has more than 4,000 affiliated physicians, and sees more than 600,000 patients annually – and has achieved an impressive patient satisfaction rate of 94%. Surgery Partners went public in 2015, and since then has built itself up into a $2.87 billion player in the healthcare sector. Last year, the company brought in $3.1 billion in total revenue, a 13.5% gain from the $2.7 billion generated in 2023. The increase reflects rising demand for quality healthcare services. Looking at the company's most recent quarterly results, Q2 2025, Surgery Partners delivered $826.2 million in revenue, marking an 8.4% year‑over‑year increase, and slightly beating forecasts by $9.24 million. Adjusted EBITDA rose 9% to $129 million, yielding a 15.6% margin. The company posted an adjusted EPS of $0.17, exceeding analyst forecasts by $0.03. Despite these solid results, the stock has remained range-bound for most of the year, held back by concerns over slowing case volume growth and cautious full-year guidance. But for Bank of America analyst Joanna Gajuk, the current share price has opened a window of opportunity. 'We rate SGRY Buy given the strong tailwinds for Ambulatory Surgery Centers (ASCs) while the stock is trading at a depressed multiple: 10x 2026E EBITDA less NCI, below the historical average of 14x and below the 14x multiple on the recent ASC platform deal (AmSurg) takeout… Being a low-cost setting (40-50% lower vs inpatient), ASCs are the beneficiaries of payors (including Medicare) pushing utilization to outpatient. The aging demographics are also driving ASC vols (utilization increases with age). Meanwhile, ASCs are a lower capital intensity business compared to acute care hospitals, yielding higher returns on invested capital,' Gajuk noted. Her bullish stance is backed by a $28 price target, implying a potential one-year upside of ~25%. (To watch Gajuk's track record, click here) Overall, Wall Street echoes a similar sentiment. Surgery Partners holds a Moderate Buy consensus rating, based on 11 recent analyst reviews that break down to 8 Buys and 3 Holds. With shares currently trading at $22.41, the average price target of $30.90 suggests a potential gain of ~38% in the year ahead. (See SRGY stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
Modi Speaks With Lula, Plans Xi Meeting as Ties With US Sour
(Bloomberg) -- Indian Prime Minister Narendra Modi talked trade with his Brazilian counterpart and is expected to head to China for the first time in seven years in August, against the backdrop of worsening ties with the US. All Hail the Humble Speed Hump Three Deaths Reported as NYC Legionnaires' Outbreak Spreads Mayor Asked to Explain $1.4 Billion of Wasted Johannesburg Funds Major Istanbul Projects Are Stalling as City Leaders Sit in Jail What England's New National Cycling Network Needs to Get Rolling Brazil's President Luiz Inacio Lula da Silva and Modi discussed the imposition of unilateral tariffs against their nations and reiterated plans to strengthen trade ties in a Thursday call that lasted nearly an hour, the Brazilian government said in a statement. Although it didn't mention Donald Trump by name, Lula's government noted that 'Brazil and India are, to date, the two countries most affected' by the wave of levies the US leader has unleashed. Modi will also attend a summit of the Beijing-led regional security grouping — the Shanghai Cooperation Organisation — and hold a bilateral meeting with President Xi Jinping on the sidelines, officials in New Delhi said, asking not to be identified to discuss internal matters. The SCO summit is scheduled to be held in Tianjin on Aug. 31 and Sept. 1. India's Ministry of External Affairs didn't immediately respond to an email seeking further comment. While Modi's call with Lula and the trip to China were previously scheduled, they take on added significance after Trump slapped India with 50% tariffs to penalize it for its trade barriers and purchases of Russian oil. India has signaled it won't halt purchases of Russian energy and has described the US tariffs as 'unjustified.' Asked on Thursday about the possibility of speeding up trade talks with India, Trump replied: 'No, not until we get it resolved.' India, Brazil, China and Russia are founding members of the BRICS group of nations, which Trump has slammed as being anti-US. Brazil has also been hit with 50% tariffs by the US leader. Bolstering commercial ties between Brazil and India was a key topic of Modi's visit to Brasilia in July. During Thursday's call, Lula and Modi also agreed to expand India's trade deal with Mercosur, the South American customs union that includes Brazil. The call included confirmation of Lula's plans to visit India next year, according to the Brazil statement. They also discussed their nation's virtual payment systems, including Brazil's Pix, which is currently under trade investigation by the US. Xi and Modi last met in October on the sidelines of the BRICS summit in Kazan shortly after both countries agreed to pull back troops from the disputed Himalayan border. The two sides have been stabilizing ties since a 2020 border clash left 20 Indian and an unknown number of Chinese soldiers dead. Xu Feihong, China's ambassador to India, gave Modi moral support over the tariffs on Wednesday. 'Give the bully an inch, he will take a mile,' Xu wrote on X over a quote from Chinese Foreign Minister Wang Yi denouncing the use of tariffs 'as a weapon to suppress other countries.' India's National Security Advisor Ajit Doval is currently in Moscow, while External Affairs Minister Subrahmanyam Jaishankar is expected to visit there on a prior scheduled trip. Modi is expected to host Russian President Vladimir Putin in India later this year. (Updates with Trump remark in seventh paragraph) The Pizza Oven Startup With a Plan to Own Every Piece of the Pie Russia's Secret War and the Plot to Kill a German CEO Digital Nomads Are Transforming Medellín's Housing AI Flight Pricing Can Push Travelers to the Limit of Their Ability to Pay A High-Rise Push Is Helping Mumbai Squeeze in Pools, Gyms and Greenery ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
